These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 20574244)

  • 1. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials.
    Bejan-Angoulvant T; Saadatian-Elahi M; Wright JM; Schron EB; Lindholm LH; Fagard R; Staessen JA; Gueyffier F
    J Hypertens; 2010 Jul; 28(7):1366-72. PubMed ID: 20574244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive treatment in the very elderly shows significant mortality benefit.
    Cardiovasc J Afr; 2008; 19(3):169-71. PubMed ID: 18568185
    [No Abstract]   [Full Text] [Related]  

  • 3. New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.
    Gueyffier F; Froment A; Gouton M
    J Hum Hypertens; 1996 Jan; 10(1):1-8. PubMed ID: 8642184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older age should not be a barrier to the treatment of hypertension.
    Aronow WS
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):514-5. PubMed ID: 18607394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hypertension in people over 80 years should not be discontinued].
    Thien T; Deinum J
    Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1713-6. PubMed ID: 18727600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
    J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antihypertensive treatment after stroke: target blood pressure and treatment recommendations].
    ; Schrader J; Lüders S; Haller H; Kolloch R; Schulz EG; Trenkwalder P; Zidek W
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2511-4. PubMed ID: 23168987
    [No Abstract]   [Full Text] [Related]  

  • 9. [Benefits of antihypertensive treatment. How much damage does it really prevent?].
    Holzgreve H
    MMW Fortschr Med; 2006 Apr; 148(14):47, 49-50. PubMed ID: 16669282
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data are needed on target blood pressure for elderly people.
    Aronow WS
    J Am Geriatr Soc; 2009 Nov; 57(11):2177; author reply 2177-8. PubMed ID: 20121982
    [No Abstract]   [Full Text] [Related]  

  • 12. Why beta-blockers should not be used as first choice in uncomplicated hypertension.
    De Caterina AR; Leone AM
    Am J Cardiol; 2010 May; 105(10):1433-8. PubMed ID: 20451690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do ancillary properties of antihypertensive drugs explain the outcome results of recent trials?
    Staessen JA; Wang J
    J Nephrol; 2002; 15(4):422-7. PubMed ID: 12243374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On-treatment diastolic blood pressure and prognosis in systolic hypertension.
    Fagard RH; Staessen JA; Thijs L; Celis H; Bulpitt CJ; de Leeuw PW; Leonetti G; Tuomilehto J; Yodfat Y
    Arch Intern Med; 2007 Sep; 167(17):1884-91. PubMed ID: 17893310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. You should treat patients over the age of 80 who have hypertension.
    Lundberg GD
    Medscape J Med; 2008; 10(8):185. PubMed ID: 18924637
    [No Abstract]   [Full Text] [Related]  

  • 16. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension.
    Fagard RH; Thijs L; Staessen JA; Clement DL; De Buyzere ML; De Bacquer DA
    J Hum Hypertens; 2009 Oct; 23(10):645-53. PubMed ID: 19225527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials.
    Staessen JA; Li Y; Thijs L; Wang JG
    Hypertens Res; 2005 May; 28(5):385-407. PubMed ID: 16156503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials.
    Czernichow S; Zanchetti A; Turnbull F; Barzi F; Ninomiya T; Kengne AP; Lambers Heerspink HJ; Perkovic V; Huxley R; Arima H; Patel A; Chalmers J; Woodward M; MacMahon S; Neal B;
    J Hypertens; 2011 Jan; 29(1):4-16. PubMed ID: 20881867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hypertension in the elderly.
    Aronow WS
    Geriatrics; 2008 Oct; 63(10):21-5. PubMed ID: 18828653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.